| Company Name | Fiscal Year | EPS (Actual) | EPS (Estimated) | Revenue (Actual) | Revenue (Estimated) | Exchange | |||
|---|---|---|---|---|---|---|---|---|---|
| Loading past events... | |||||||||
|
Monday - Jul 14, 2025 |
|||||||||
| Q2 FY25 | $0.29 | $0.28 | $2.08B | $2.07B |
NASDAQ |
||||
|
FB Financial
FBK
|
Q2 FY25 | $0.88 | $0.89 | $147.53M | $136.32M |
NYSE |
|||
|
Equity Bancshares
EQBK
|
Q2 FY25 | $0.99 | $0.90 | $57.56M | $60.46M |
NYSE |
|||
|
Simulations Plus
SLP
|
Q3 FY25 | $0.45 | $0.26 | $20.36M | $20.93M |
NASDAQ |
|||
|
Jewett-Cameron Trading
JCTC
|
Q3 FY25 | -$0.18 | - | $12.61M | - |
NASDAQ |
|||
|
Lexaria Bioscience
LEXXW
|
- | -$0.21 | -$0.15 | $174K | $137K |
NASDAQ |
|||
